237 related articles for article (PubMed ID: 9004072)
1. Worsening of psychosis with clozapine and selective serotonin reuptake inhibitor combination: two case reports.
Chong SA; Tan CH; Lee HS
J Clin Psychopharmacol; 1997 Feb; 17(1):68-9. PubMed ID: 9004072
[No Abstract] [Full Text] [Related]
2. Selective serotonin reuptake inhibitor modulation of clozapine effects on cognition in schizophrenia.
Purdon SE; Snaterse M
Can J Psychiatry; 1998 Feb; 43(1):84-5. PubMed ID: 9494753
[No Abstract] [Full Text] [Related]
3. [Possible combination of clozapine and specific serotonin reuptake inhibitors?].
Caroli F; Aymard N; Viala A; Smagghe PO
Encephale; 1995; 21(6):482-3. PubMed ID: 8674476
[No Abstract] [Full Text] [Related]
4. High-Dose Fluvoxamine Augmentation to Clozapine in Treatment-Resistant Psychosis.
Leising J; Barr AM; Procyshyn RM; Ainsworth NJ; White RF; Honer W; Vila-Rodriguez F
J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):186-190. PubMed ID: 33587389
[TBL] [Abstract][Full Text] [Related]
5. [New antidepressive agents].
LaBranche S
Union Med Can; 1995 Nov; 124(3):8-13. PubMed ID: 8560639
[No Abstract] [Full Text] [Related]
6. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline.
Allen L; Tejera C
Am J Psychiatry; 1994 Jul; 151(7):1096-7. PubMed ID: 8010373
[No Abstract] [Full Text] [Related]
7. Sertraline in the treatment of clozapine-induced obsessive-compulsive behavior.
Rahman MS; Grace JJ; Pato MT; Priest B
Am J Psychiatry; 1998 Nov; 155(11):1629-30. PubMed ID: 9812137
[No Abstract] [Full Text] [Related]
8. [Pharmacotherapy of chronic schizophrenic psychoses--neuroleptic plus serotonin reuptake inhibitor?].
Salzmann E; Eikelmann B
Psychiatr Prax; 1997 Sep; 24(5):253. PubMed ID: 9417552
[No Abstract] [Full Text] [Related]
9. Fluvoxamine augmentation in clozapine-resistant schizophrenia: an open pilot study.
Silver H; Kushnir M; Kaplan A
Biol Psychiatry; 1996 Oct; 40(7):671-4. PubMed ID: 8886304
[No Abstract] [Full Text] [Related]
10. [Effect of sertraline on blood clozapine].
Darchy A; Fdhil H; Canceil O
Encephale; 1998; 24(2):156-7. PubMed ID: 9622795
[No Abstract] [Full Text] [Related]
11. Potential withdrawal syndrome associated with SSRI discontinuation.
Lazowick AL; Levin GM
Ann Pharmacother; 1995 Dec; 29(12):1284-85. PubMed ID: 8672834
[No Abstract] [Full Text] [Related]
12. Selective serotonin reuptake inhibitor discontinuation with ECT and withdrawal symptoms.
Markowitz JS
J ECT; 1998 Mar; 14(1):55. PubMed ID: 9661096
[No Abstract] [Full Text] [Related]
13. Combination of clozapine and aripiprazole: a promising approach in treatment-resistant schizophrenia.
Ziegenbein M; Sieberer M; Calliess IT; Kropp S
Aust N Z J Psychiatry; 2005 Sep; 39(9):840-1. PubMed ID: 16168043
[No Abstract] [Full Text] [Related]
14. Response to "Sertraline and isocarboxazid cause a serotonin syndrome".
Kirrane R; Bodner R; Lynch T
J Clin Psychopharmacol; 1995 Apr; 15(2):144. PubMed ID: 7782491
[No Abstract] [Full Text] [Related]
15. Hypomania associated with mirtazapine augmentation of sertraline.
Soutullo CA; McElroy SL; Keck PE
J Clin Psychiatry; 1998 Jun; 59(6):320. PubMed ID: 9671349
[No Abstract] [Full Text] [Related]
16. Risk of fetal anomalies with exposure to selective serotonin reuptake inhibitors.
Grush LR
JAMA; 1998 Jun; 279(23):1873. PubMed ID: 9634252
[No Abstract] [Full Text] [Related]
17. Sertraline and psychotic symptoms: a case series.
Popli AP; Fuller MA; Jaskiw GE
Ann Clin Psychiatry; 1997 Mar; 9(1):15-7. PubMed ID: 9167832
[TBL] [Abstract][Full Text] [Related]
18. Benefits of combining aripiprazole to clozapine: three case reports.
Rocha FL; Hara C
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1167-9. PubMed ID: 16647796
[TBL] [Abstract][Full Text] [Related]
19. Management of clozapine-induced obsessive-compulsive symptoms in a man with schizophrenia.
Zink M; Knopf U; Kuwilsky A
Aust N Z J Psychiatry; 2007 Mar; 41(3):293-4. PubMed ID: 17464712
[No Abstract] [Full Text] [Related]
20. Restarting clozapine: a case report.
Barrons E; Johnson E; Nynkowski P
Psychiatr Serv; 1996 Jan; 47(1):92. PubMed ID: 8925356
[No Abstract] [Full Text] [Related]
[Next] [New Search]
